Insmed reported $107.6M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Cytokinetics 0 0 Dec/2023
Dynavax Technologies USD 75.69M 1.28M Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
Insmed USD 107.6M 6.89M Jun/2025
Novartis USD 6.31B 584M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025